Jushi Appoints Former Anheuser Busch Executive As COO
Cannabis operator Jushi Holdings Inc (OTC:JUSHF) has appointed former Anheuser Busch Inbev Sa (NYSE:BUD) global supply chain executive Leonardo Garcia-Berg as the company’s Chief…
VIA optronics AG Appoints Dr. Markus Peters as Chief Financial Officer; Co. Reaffirms FY21 Guidance
VIA optronics AG (NYSE:VIAO) (“VIA”), a leading supplier of interactive display systems and solutions, today announced that its Supervisory Board has appointed Dr. Markus Peters as Chief Financial Officer
Cidara Therapeutics Names James Levine Has Resigned As CFO
Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that
Genesco Shareholder, Legion Partners, Urges Shareholders To Vote On White Proxy Card
Legion Partners Asset Management, LLC (together with its affiliates, “Legion Partners” or “we”), which collectively with the other participants in its solicitation beneficially owns approximately
Boeing Analyst: CFO Faces ‘No Shortage Of Challenges’ In New Role
Boeing Co (NYSE: BA) shares traded slightly higher on Thursday after the company announced a new CFO on Wednesday.
ContextLogic Finance Chief Steps Down
Mobile eCommerce platform ContextLogic Inc (NASDAQ:WISH) has said its Chief Financial Officer, Rajat Bahri, has notified the Board of Directors of…
Activist Fund Elliott Management Wants GlaxoSmithKline Board Shakeup For ‘Years Of Under Management’
Elliott Management has finally made its intentions around GlaxoSmithKline plc (NYSE: GSK) known and calls for changes to rescue GSK from what it called "years of under-management."
Pulse Biosciences Stock Is Trading Higher After Company’s Chairman Agrees To Buy Shares Worth $50M
Pulse Biosciences Inc’s (NASDAQ:PLSE) Board Chairman, Robert W. Duggan, will purchase 3.04 million common shares at $16.40 per share in…
GeoPark Co-Founder, Former Chair Issues Investor Presentation, Suggests Potential Director Candidates
Presentation Illustrates How Jim Park Runs Company as an Imperial CEO Who Resists True Independence and Strategic Input from the Board
Also Details Need for Independent Directors Who Will be Objective Advocates for
Adamis Pharma Sends Letter To Shareholders, Addresses Jerald Hammann’s ‘Costly, Distracting, Misguided’ Campaign
July 1, 2021
Dear Stockholders,
The Board of Directors (the "Board") appreciates your continued investment in Adamis Pharmaceuticals Corporation ("Adamis" or the "Company" or